Cargando…
Preoperative Serum Sodium Level as a Prognostic and Predictive Biomarker for Adjuvant Therapy in Esophageal Cancer
BACKGROUND: Low serum sodium has been associated with unfavorable outcome in several cancers. The prognostic value of serum sodium in esophageal carcinoma (EC) remains unclear. This study aimed to investigate preoperative serum sodium in association with outcome and survival benefit of adjuvant ther...
Autores principales: | Wang, Qifeng, Peng, Lin, Han, Yongtao, Li, Tao, Dai, Wei, Wang, Yi, Wu, Lei, Wei, Yang, Xie, Tianpeng, Fang, Qiang, Li, Qiang, Lang, Jinyi, Cao, Bangrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858663/ https://www.ncbi.nlm.nih.gov/pubmed/33552948 http://dx.doi.org/10.3389/fonc.2020.555714 |
Ejemplares similares
-
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
por: Cao, Bangrong, et al.
Publicado: (2022) -
Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020) -
Prognostic significance and postoperative chemoradiotherapy guiding value of mean platelet volume for locally advanced esophageal squamous cell carcinoma patients
por: Zhang, Wei, et al.
Publicado: (2023) -
Pretreatment Low Serum Sodium as a Prognostic Factor for Patients with Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy
por: Lu, Jianchao, et al.
Publicado: (2022) -
Progression-Free Survival as Early Efficacy Endpoint in Resectable Esophageal Cancer Treated With Neoadjuvant Therapy: A Systematic Review
por: Zhu, Jie, et al.
Publicado: (2022)